News
Matrix Effects on P21 CSF Quantification: A Val...
Matrix effects can distort P21 quantification in CSF. This article outlines a validation framework, reviews current data, and explains how to read published
Matrix Effects on P21 CSF Quantification: A Val...
Matrix effects can distort P21 quantification in CSF. This article outlines a validation framework, reviews current data, and explains how to read published
Argireline Stability in Compounded Topical Form...
Learn how advanced HPLC-MS/MS method development under ICH Q1A(R2) stress conditions ensures Argireline stability in compounded topical
Argireline Stability in Compounded Topical Form...
Learn how advanced HPLC-MS/MS method development under ICH Q1A(R2) stress conditions ensures Argireline stability in compounded topical
Validating Argireline Quantification in Topical...
Learn how to transfer HPLC-MS methods for Argireline in topical serums and overcome matrix effects that can skew peptide quantification. Practical steps
Validating Argireline Quantification in Topical...
Learn how to transfer HPLC-MS methods for Argireline in topical serums and overcome matrix effects that can skew peptide quantification. Practical steps
Best HPLC-MS Methods for Argireline and P21 in ...
A recent study optimized HPLC-MS for simultaneous Argireline and P21 quantification in intranasal formulations. Matrix effects from chitosan and P21
Best HPLC-MS Methods for Argireline and P21 in ...
A recent study optimized HPLC-MS for simultaneous Argireline and P21 quantification in intranasal formulations. Matrix effects from chitosan and P21
Designing an RCT for P21 Intranasal Delivery in...
A VA-based RCT design tests intranasal P21 in veterans with AUD on GLP-1s, using crossover and dose-finding phases to assess safety and efficacy
Designing an RCT for P21 Intranasal Delivery in...
A VA-based RCT design tests intranasal P21 in veterans with AUD on GLP-1s, using crossover and dose-finding phases to assess safety and efficacy
Validating P21 Co-Administration with Semax in ...
A rodent crossover study shows co-administering P21 with Semax intranasally reduces peak P21 concentration by 34% but not total exposure, highlighting
Validating P21 Co-Administration with Semax in ...
A rodent crossover study shows co-administering P21 with Semax intranasally reduces peak P21 concentration by 34% but not total exposure, highlighting